A series of new thiazole based hydrazones have been synthesized and their antimicrobial and α-amylase (type-II diabetes) inhibitory activities have been evaluated. The structures of synthesized derivatives were elucidated by various spectral techniques including FTIR, NMR and mass spectrometry. Antibacterial activity tests were performed against two Gram-positive (Bacillus subtilis and Staphylococcus aureus) and two Gram-negative (Escherichia coli and Pseudomonas aeruginosa) bacterial strains. Two fungal strains (Candida albicans and Aspergillus niger) were taken for testing antifungal activity. Among the tested derivatives, compound 3d was found to be the most potent against all tetsed bacterial and fungal strains. The α-amylase inhibitory activity of all compounds was also assayed using the starch iodine method. Derivatives 3j and 3k exhibited the best inhibitory activity against α-amylase enzyme with IC50 values of 0.26 ± 0.06 and 0.32 ± 0.02 μM, respectively, in comparison to acarbose (IC50 = 0.11 ± 0.00 μM) as standard reference. The results of the biological activity evaluation were confirmed by docking studies.
Similar content being viewed by others
References
E. A. Nyenwe, T. W. Jerkins, G. E. Umpierrez, and A. E. Kitabchi, Metabolism, 60, 1 – 23 (2011).
J. E. Gerich, Endocr. Rev., 19, 491 – 503 (1998).
E. Bonora, and M. Muggeo, Diabetologia, 44, 2107 – 2114 (2001).
X. Qin, L. Ren, X. Yang, et al., J. Struct. Biol., 174, 196 – 202 (2011).
P. M. de Sales, P. M. de Souza, L. A. Simeoni, et al., J. Pharm. Pharm. Sci., 15, 141 – 183 (2012).
Y. He, B. Wu, J. Yang, et al., Bioorg. Med. Chem. Lett., 13, 3253 – 3256 (2003).
V. Moudgal, T. Little, D. Boikov, and J. A. Vazquez, Antimicrob. Agents Chemother., 49, 767 – 769 (2005).
M. S. Al-Saadi, H. M. Faidallah, and S. A. Rostom, Arch. Pharm., 341, 424 – 434 (2008).
P. C. Lv, K. R. Wang, Y. Yang, et al., Bioorg. Med. Chem. Lett., 19, 6750 – 6754 (2009).
F. Chimenti, B. Bizzarri, E. Maccioni, et al., Bioorg. Med. Chem. Lett., 17, 4635 – 4640 (2007).
A. Cukurovali, I. Yilmaz, S. Gur, and C. Kazaz, Eur. J. Med. Chem., 41, 201 – 207 (2006).
S. K. Bharti, G. Nath, R. Tilak, and S. K. Singh, Eur. J. Med. Chem., 45, 651 – 660 (2010).
S. Rollas and S. Kucukguzel, Molecule, 12, 1910 – 1939 (2007).
H. N. Dogan, A. Duran, S. Rollas, et al., Bioorg. Med. Chem., 10, 2893 – 2898 (2002).
R. Kalsi, M. Shrimali, T. N. Bhalla, and J. P. Barthwal, Indian J. Pharm. Sci., 41, 353 – 359 (2006).
L. Popiolek, A. Biernasiuk, and A. Malm, Phosphorus Sulphur, 190, 251 – 260 (2015).
L. Popiolek, A. Biernasiuk, and A. Malm, J. Heterocycl. Chem., 53, 479 – 486 (2016).
F. Hueso-Urena, A. L. Penas-Chamorro, M. N. Moreno-Carretero, et al., J. Chem. Crystallogr., 29, 283 – 286 (1999).
A. Ozdemir, G. Turan-Zitouni, Z. A. Kaplancikli, and Y. Tunali, J. Enzyme Inhib. Med. Chem., 24, 825 – 831 (2009).
G. Kucukguzel, A. Kocatepe, E. De Clercq, et al., Eur. J. Med. Chem., 41, 353 – 359 (2006).
U. Ashiq, R. Ara, M. Mahroof-Tahir, et al., Chem. Biodivers., 5, 82 – 92 (2008).
S. Rollas, N. Gulerman, and H. Edeniz, Farmaco, 57, 171 – 174 (2002).
J. R. Dimmock, S. C. Vasishtha, and J. P. Stable, Eur. J. Med. Chem., 35, 241 – 248 (2000).
P. C. Lima, I. M. Lima, K. C. Silva, et al., Eur. J. Med. Chem., 35, 187 – 203 (2000).
R. Todeschini, A. L. P. de Miranda, K. C. M. da Silva, et al., Eur. J. Med. Chem., 33, 189 – 199 (1998).
A. Imramovsky, S. Polanc, J. Vinsova, et al., Bioorg. Med. Chem., 15, 2551 – 2559 (2007).
Y. Janin, Bioorg. Med. Chem., 15, 2479 – 2513 (2007).
S. A. M. El-Hawasch, W. A. E. Abdel, and M. A. El-Dewellawy, Arch. Pharm. Chem. Life Sci., 339, 14 – 23 (2006).
M. T. Cocco, C. Congui, V. Lilliu, and V. Onnis, Bioorg. Med. Chem., 14, 366 – 372 (2006).
J. Savini, I. Chiasserini, V. Travagli, et al., Eur. J. Med. Chem., 39, 113 – 122 (2004).
A. Bijev, Lett. Drug Des. Discov., 3, 506 – 512 (2006).
G. A. Silva, I. M. M. Casta, F. C. F. Brito, et al., Bioorg. Med. Chem., 12, 3149 – 3158 (2004).
M. T. Abdel-Aal, W. A. El-Sayed, and E. H. El-ashry, Arch. Pharm. Chem. Life Sci., 339, 656 – 663 (2006).
A. Walcourt, M. Loyevsky, D. B. Lovejoy, et al., Int. J. Biochem. Cell Biol., 36, 401 – 407 (2004).
A. S. El-Tabl, F. A. Aly, M. M. E. Shakdofa, and A. M. E. Shakdofa, J. Coord. Chem., 63, 700 – 712 (2010).
V. I. Nikulin, N. Y. Lugovskaya, and N. N. Sveshnikov, Pharm. Chem. J., 28, 13 – 15 (1994).
L. B. Kilgore, J. H. Ford, and W. C. Wolfe, Ind. Eng. Chem., 34, 494 – 497 (1942).
Y. Liu, A. Saldivar, and J. Bess, Biochemistry, 42, 8862 – 8869 (2003).
L. Shapiro, K. Geiger, L. Freedman, J. Org. Chem., 25, 1860 – 1865 (1960).
S. N. Dhawan, S. Dasgupta, S. Mor, and S. C. Gupta, Indian J. Heterocycl. Chem., 2, 155 – 158 (1993).
K. N. Sawhney and T. L. Lemke, J. Org. Chem., 48, 4326 – 4329 (1983).
S. Mor and S. Nagoria, Chem. Biol. Interface, 5, 389 – 400 (2015).
R. Mohil, D. Kumar, and S. Mor, J. Hetrocyclic. Chem., 51, 203 – 211 (2014).
M. A. Mosaddik and M. E. Haque, Phytother. Res., 17, 1155 – 1157 (2003).
Z. Xiao, R. Storms and A. Tsang, Anal. Biochem., 351, 146 – 148 (2006).
M. Duhan, R. Singh, M. Devi, et al., J. Biomol. Struct. Dyn. DOI: 10.1080 / 07391102.2019.1704885 (2019)
MarvinSketch 19.19.0 (2019), ChemAxon (http://www.chemaxon.com).
E. F. Pettersen, T. D. Goddard, C. C. Huang, et al., J. Comput. Chem., 25, 1605 – 1612 (2004).
O. Trott and A. J. Olson, J. Comput. Chem., 31, 455 – 461 (2010).
Dassault Systèmes BIOVIA, Discovery Studio Visualizer v17.2.0.16349, Dassault Systèmes: San Diego (2016).
CONFLICT OF INTEREST
The authors declare that they have no conflicts of interest.
Funding
The authors are grateful to the University Grants Commission (New Delhi, India) [Sr. No. 2061610093 Ref. No.19/06/2016(i)EU-V, dated 26-12-2016] and the Council of Scientific and Industrial Research (New Delhi, India) [CSIR no. 09/752(0060)/2016-EMR-I] and [CSIR no. 09/752(0104)/2019-EMR-I] for providing financial support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Mor, S., Khatri, M., Sindhu, S. et al. Synthesis, Antimicrobial Activity, α-Amylase Inhibitory Tests and Molecular Docking Studies of Thiazole Based Hydrazones Derived from 2-acyl-(1H)-indene-1,3(2H)-diones. Pharm Chem J 56, 925–934 (2022). https://doi.org/10.1007/s11094-022-02728-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-022-02728-6